Ballicules.com
Not available in the U.S.

Voglibose

BASEN

Voglibose ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Voglibose ballicule

What it isVoglibose is an alpha-glucosidase inhibitor that delays intestinal digestion of complex carbohydrates to blunt postprandial glucose excursions.

Why this oneIt is used mainly in Japan and other Asian countries as an adjunct for type 2 diabetes and impaired glucose tolerance.

What limits itIt commonly causes flatulence, abdominal distension, and diarrhea, and is not marketed in the United States.

Voglibose molecular structure (skeletal formula)
Molecular structure: Voglibose

NO BOXED WARNINGS

Principal riskNo FDA boxed warning.

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability1 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4

Open Voglibose in the interactive console ↗